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Abstract
Variation in genes coding for nicotinic acetylcholine receptor (nAChR) subunits affect cogni-
tive processes and may contribute to the genetic architecture of neuropsychiatric disorders.
Single nucleotide polymorphisms (SNPs) in theCHRNA4 gene that codes for the alpha4 sub-
unit of alpha4/beta2-containing receptors have previously been implicated in aspects of
(mostly visual) attention and smoking-related behavioral measures. Here we investigated the
effects of six synonymous but functionalCHRNA4 exon 5 SNPs on the N100 event-related
potential (ERP), an electrophysiological endophenotype elicited by a standard auditory odd-
ball. A total of N = 1,705 subjects randomly selected from the general population were studied
with electroencephalography (EEG) as part of the German Multicenter Study on nicotine
addiction. Two of the six variants, rs1044396 and neighboring rs1044397, were significantly
associated with N100 amplitude. This effect was pronounced in females where we also
observed an effect on reaction time. Sequencing of the complete exon 5 region in the popula-
tion sample excluded the existence of additional/functional variants that may be responsible
for the observed effects. This is the first large-scale population-based study investigation the
effects ofCHRNA4SNPs on brain activity measures related to stimulus processing and atten-
tion. Our results provide further evidence that common synonymousCHRNA4 exon 5 SNPs
affect cognitive processes and suggest that they also play a role in the auditory system. As
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N100 amplitude reduction is considered a schizophrenia-related endophenotype the SNPs
studied here may also be associated with schizophrenia outcomemeasures.
Introduction
Various lines of basic, “translational” and clinical research suggest that the nicotinic cholinergic
system modulates cognitive processes and that it plays an import role in a number of neuropsy-
chiatric disorders such as schizophrenia, Alzheimer’s dementia, addiction and pain [1–4].
Therefore nicotinic acetylcholine receptors (nAchRs) are considered promising drug targets.
NAchRs are ligand-gated ion channels consisting of 5 subunits surrounding a central pore that
upon stimulation opens for influx of sodium and calcium ions into the neuron. The neurophys-
iological and pharmacological properties of NAchRs depend on the subunit composition that
is highly variable [5]. The most abundant high-affinity NAchRs in the human brain, alpha4-
and beta2-containing receptors, consist of two alpha4, two beta2 subunits and a fifth subunit
that can be either alpha4, beta2 or a third kind of subunit [6]. Natural variation in CHRNA4,
the gene coding for the alpha4 subunit, has been associated with a number of cognitive (endo)
phenotypes and with aspects of nicotine dependence [7]. One “hot spot” for genetic variation is
exon five of the CHRNA4 gene where common synonymous single nucleotide polymorphisms
(SNPs) have been the focus of previous research. In these previous studies addressing the role
of SNPs in the exon 5 or other regions of the CHRNA4 gene in human cognition or neuropsy-
chiatric disorders have by and large either investigated the association of these SNPs with cog-
nitive (endo)phenotypes such as electrophysiological or brain imaging measures [8, 9] in
rather small numbers of subjects or with “clinical”measures such as smoking status and related
outcome measures in larger cohorts [10, 11]. The existing literature on the role of rs1044396 in
human cognition has recently been reviewed by Greenwood et al. [7]. The authors suggest that
the CHRNA4 rs1044396 variants affect attention and that the cognitive phenotype of this C/T
SNP is characterized by greater ability of T allele carriers to preferentially process events in the
attentional focus compared to events outside the attentional focus. However, in all of the previ-
ous electrophysiological or imaging studies including an own earlier functional magnetic reso-
nance imaging (fMRI) study only a limited number of subjects were investigated and in most
of theses studies the visual system was investigated using fMRI. Only one previous study inves-
tigated the impact of rs1044396 variants on auditory stimulus processing using electroencepha-
lography (EEG) [12]. In this small-scale study subjects homozygous for the T allele exhibited
higher auditory N1 amplitudes than carriers of the C allele. To our knowledge no replication of
this study has been published thus far. Furthermore it has been argued that cognitive research
suffers from an over-representation of certain population groups (i.e. college students) ques-
tioning the “generalizability” of the results [13]. In the present study we therefore sought to fur-
ther investigate the impact of CHRNA4 variants including rs1044396 on the ERP N1
component elicited by a “standard” two-stimulus auditory oddball task [14]. Here we applied
the task to a large population-based sample of healthy German subjects [15]. Genotype effects
on the N1 ERP were controlled for other variables such as smoking status and age.
Subjects, Materials and Methods
Study Sample
As part of the German Multicenter Study on Nicotine Dependence [15, 16] (www.nicotine-
research.com), subjects were selected from the official local residents' registers and contacted
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by mail with the request to participate in the study. N = 49,000 subjects were contacted by let-
ter, N = 4,140 subjects responded. With these subjects an initial 10-minute pre-screening was
conducted on the phone. Those subjects who met the initial inclusion/exclusion criteria were
invited for an in-depth screening investigation which included a standard medical examina-
tion, a psychiatric interview (SCID-1) [17], drug screening, a quantitative assessment of daily
alcohol consumption and COHb measurements. Inclusion criteria: speaking German on
mother-tongue level with grandparents of participants being born in Germany or an adjacent
country. Furthermore, participants were required to be either current smokers (minimum one
cigarette per day) or never-smoking individuals (no more than 20 cigarettes during their life).
Currently abstinent smokers were not allowed to participate in the study. In order to confirm
smoking status and to assess the degree of nicotine dependency, the Fagerstrom Test for Nico-
tine Dependence (FTND) was applied [18] and steady state exposure to cigarette smoke was
assessed by measuring exhaled carbon monoxide (CO). Exclusion criteria: alcohol- or sub-
stance abuse within previous six months (DSM-IV), alcohol- or substance dependence
(DSM-IV), other DSM-IV axis-1 psychiatric diagnosis during the last six months, serious
impairments of vision/hearing, pregnancy, CNS-medication within previous six months, neu-
rological illness (lifetime) or any other medical condition that may impact on brain function.
From the 2,396 subjects that were investigated in the German Multicenter Study on Nicotine
Dependence [15] (www.nicotine-research.com), n = 1,705 subjects were used for the present
study since artifact-free EEG data and N100 peak amplitudes from electrode position Cz were
available from these subjects (Table 1).
The study was approved by the ethics committees of the local universities (Central Institute
of Mental Health Mannheim, Charite Berlin, Friedrich-Alexander University Erlangen-Nürn-
berg, Heinrich-Heine University Duesseldorf; Rheinisch-Westfälische Technische Hochschule
(RWTH) Aachen; University Hospital Bonn) at each study site and was conducted according
to the declaration of Helsinki. Written informed consent was obtained from all participants.
An identical standard operating procedure (SOP) and measurement time table was applied
across all study sites including regular site monitoring and data quality controls. As part of the
study, demographical and smoking-related information was obtained (Table 1). Electrophysio-
logical experiments (see below) were conducted before a standardized lunch (between 11:30am
and 02:00pm) and 1–3 hours after the last cigarette in smokers. This particular time window
was selected to minimize acute nicotine as well as nicotine withdrawal-related effects. 45ml
venous blood was taken for plasma cotinine measurements and genetic investigations (see
below). For further details on study-related procedures see Lindenberg et al. [15].
Table 1. Socio-demographic Data.
Parameter Entire sample TT CT CC
N = 1705 N = 492 N = 846 N = 367
Age in years (SD) 35.3 (13.1) 34.7 (13.1) 35.2 (12.9) 36.4 (13.7)
% Females 56.8 53.7 58.6 56.9
Years of school education (SD) 11.7 (1.6) 11.8 (1.6) 11.7 (1.6) 11.7 (1.7)
% smokers 46.9 48.6 45.5 48
Exhaled CO in parts per million (SD) 6.8 (9.5) 7.5 (10.3) 6.3 (8.9) 6.9 (9.6)
FTND# (SD) 3.1 (2.6) 3.0 (2.6) 3.0 (2.5) 3.4 (2.8)
Age of onset (years) # (SD) 16.1 (3.5) 16.3 (3.5) 16.0 (3.4) 16.0 (3.6)
Cigarettes per life time§ (SD) 6.4 (10.1) 6.9 (12.0) 6.0 (9.0) 6.9 (9.9)
#Only obtained in smokers.
§Only obtained in never-smokers.
doi:10.1371/journal.pone.0152984.t001
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Electrophysiology/Functional Neuroimaging
Task conditions: Subjects had to keep their eyes closed during the EEG experiment. Firstly, five
minutes of continuous “resting state” EEG was recorded. Immediately thereafter, EEG data
was collected during an auditory oddball task—a reaction time task that requires a selective
response to auditory stimuli. 240 auditory stimuli were presented binaurally by headphones at
70-dB sound pressure level and in (pseudo-)randomized order. Task instruction: to respond to
target stimuli as quickly and accurately as possible (right-hand button press). Rare target stim-
ulus: sinus tone of 2,000Hz (20% of stimuli), frequent non-target stimulus: sinus a tone of
1,500Hz (80% of stimuli) with stimulus duration of 50ms (including rise and fall time). Aver-
age inter-stimulus interval: 1,750ms (range 1,500–2,000ms).
EEG data acquisition: Across study sites, EEG recording was conducted with a 32-channel
EEG system from Brain Products, Gilching, Germany (BrainAmp DC1, three study sites) or
Neuroscan Inc. Sterling, VA, USA (Synamps 21, four study sites). All study sites used the
2-channel EEG cap “EasyCap” (EEG Recording Caps and Products GmbH1, Breitbrunn, Ger-
many). 29 scalp electrodes were placed according to the extended 10–20 system. Additional two
electrodes were fixed at the outer canthi and above lower orbital portion of the orbicularis oculi
muscle to detect horizontal and vertical eye movements. For recording the electrocardiogram
(ECG), another electrode was attached to the left wrist. EEG was recorded relative to the Cz refer-
ence. Sampling rate of the analogue data: 250Hz. For N100 analysis (see below), a time constant
of 0.1 sec. was preferred with a low-pass filter of 45Hz (both with slope of 12db). A 50Hz notch
infinite impulse response (IIR) filter was used. Impedance was kept below 10kO for all electrodes.
EEG data analysis: Brain Vision Analyzer1 (Brain Products GmbH) was used for EEG anal-
ysis. Artifact detection was conducted semi-automatically and visually controlled. Voltage
changes of more than 70μV were regarded as artifacts and excluded from further analysis.
Average number of artifact-free and correctly responded target trials: 45.0 (SD 2.37). EEG data
were then re-referenced to common average, segmented into 1,000ms epochs (-200ms to
800ms around target stimuli), corrected for baseline shifts and averaged. The event-related
potential (ERP) N100 amplitude (μV) against baseline was calculated for the target condition
(time window 90-110ms post stimulus). Remark: the ERP N100 was preferred instead of the
ERP P300 because an earlier study conducted by Espeseth et al. [12] indicated a stronger
rs1044396 genotype effect on N100.
For functional neuroimaging analyses, we performed current source density analyses of the
event-related EEG (N100 amplitude, ±8 ms peak amplitude) in 3-D Talairach space using
sLORETA [19, 20] following N100 analysis procedures previously described by us [21–23].
The “current source density” (μA/mm3) is defined as the divergence of the current density, i.e.,
the divergence is a spatial derivative. However, sLORETA is dimensionless, because it stan-
dardizes the current density (the denominator has the same units as the numerator), i.e., sLOR-
ETA units are simply units of standardized current density. The version of sLORETA
employed uses the digitized Talairach atlas estimating the current density distribution of brain
electrical activity on a dense grid of 6430 voxels at 5mm spatial resolution [20]. The solution
space (the three dimensional space where the inverse problem is solved) is restricted to the cor-
tical grey matter and hippocampus in the Talairach space. Only voxels significant at P = 0.01
or P = 0.05 level after correction for multiple comparisons are retained, i.e., the significance of
changes in activity compared to baseline is assessed using non-parametric analyses adapted to
source comparisons and implemented in sLORETA which corrects for multiple comparisons
(statistical non-parametric mapping, SnPM) [24]. Standardized current density is depicted by
co-registration of LORETA group maps with standard Talairach space and subsequently con-
verted to a high-resolution MRI image.
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Genotyping
Genotyping was performed at the Cologne Center for Genomics, University of Cologne
blinded to phenotype status of the subjects. DNA was extracted from fresh frozen EDTA blood
using the Qiagen FlexiGene DNA Kit according to the manufacturer's protocol. DNA quantifi-
cation was done by using the NanoDrop Spectrophotometer (ND-1000, Thermo Fischer Scien-
tific, Wilmington DE, USA) and we normalized the amount of DNA input based on RNase P
copy number measurements using the TaqMan human RNase P assay (Applied Biosystems1,
Foster City, CA, USA). Genotyping of the six CHRNA4 (HGNC:1958) SNPs (5’-rs1044393,
rs1044394, rs2229959, rs2229960, rs1044396, rs1044397-3’, see also Fig 1) which cover most of
the CHRNA4 exon 5 coding region, was performed with TaqMan SNP genotyping assays.
These SNPs were selected based on previous research from our group [25] and others. Geno-
typing call rates were between 97.8% and 99.6%. Genotype frequencies at all six SNPs did not
deviate from Hardy-Weinberg equilibrium (P> 0.05).
Sequencing
A systematic analysis of the complete exon 5 of CHRNA4 gene was performed in three overlap-
ping fragments by polymerase chain reaction (PCR) and direct sequencing. The PCR primers
were designed with the free internet tool Primer3 v.0.4.0 (http://bioinfo.ut.ee/primer3-0.4.0/).
PCR products were purified by Exo/SAP digestion with Exonuclease I (New England Biolabs,
Beverly, MA) and Shrimp Alkaline Phosphatase (Promega, San Diego, USA) and directly
sequenced using the ABI PRISM BigDye1 Terminator v1.1 Cycle Sequencing Kit and the ABI
Fig 1. Pairwise correlation (r-squared) between the 6 SNPs on exon 5 of the CHRNA4 gene in our
sample. The image was created using Haploview [43]. Genomic positions are given in hg19 coordinates.
doi:10.1371/journal.pone.0152984.g001
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3730 sequencing instrument (Applied Biosystems, Foster City, CA, USA) following the manu-
facturer's instructions. All primer sequences and PCR conditions can be obtained on request
from the authors. All sequences were analyzed using Mutation Surveyor software v3.2.
Remark: In an earlier paper, we have discussed the possibly of population stratification in
our sample [16]. We did not genotype a standard panel of ancestry-informative SNPs to con-
trol for genetic stratification since we investigated a genetically highly homogeneous sample of
subjects with Germany ancestry (or from adjacent countries) and because participants were
randomly selected from the general population. Also, the European autosomal gene pool is
quite small, in particular in northern and middle Europe populations [26].
Statistical Analyses
For the primary analysis, a linear regression model with genotype predicting N100 amplitude
was identified performing a stepwise backward selection with the statistical GLM Procedure
(proc glm) implemented in SAS (SAS for Unix, version 9; SAS Institute Inc., Cary, NC, USA;
http://www.sas.com). We performed best-fitting model selection based on an unconstrained
genetic model. We included potentially modifying socio-demographic measures and smoking
status as predictors (Table 2). Interactions among the predictors were tested considering up to
3-factor interactions. After the best model was selected, the recessive genetic model was evalu-
ated based on previous literature [27] in addition to the unconstrained model. The best fitting
model for the N100 ERP was used for testing the genotype effect on the corresponding behav-
ioral measure, i.e., reaction time during oddball task condition (secondary analysis).
Follow-up EEG-based sLORETA (N100) analyses: For between-group analyses, standard-
ized current density are corrected for the effects of relevant covariates (age, gender, study site,
education) before the residuals were entered into the final sLORETA analyses.
We finally addressed the question whether the 28 variants on exon 5 that were found in
1590 successfully sequenced samples were associated with N100 amplitude at electrode
Table 2. Linear Regression Analyses: Variables.
Variable Description Data type1 Data range
Sex subject gender Cat female, male
Age subject age (years) Quan 18–66
Center sampling location Cat Aachen, Bonn, Berlin, Düsseldorf, Erlangen,
Mainz, Mannheim
School school attendance (years) Quan 6–15
Smoker smoking status Cat smoker, never-smoker
cig_day* count of consumed cigarettes per day Quan 0.25–70
Ftnd* Fagerström Test "FTND" (score) Ord 0–10
pack_years* estimated sum of number of cigarettes packages consumed in life time
(corrected for times of abstinence)
Quan 0.05–175
onset* age of smoking onset (years) Quan 6–44
Cohb* COHb (exhaled CO in parts per million) Quan 0–82
N100 N100 ERP amplitude μV (Cz) ** Quan -1.58–11.95
rs1044396 Genotype Cat CC, CT, TT
List of variables evaluated by the stepwise backward selection in linear regression models.
1: cat = categorial, quan = quantitative, ord = ordinal.
*These variables were only included in the group of smokers. ERP = Event-related potential N100.
** Standardized scores.
doi:10.1371/journal.pone.0152984.t002
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position Cz. Since all those variants had very low minor allele frequencies (MAF0.0054) we
analyzed the combined set of variants using the established SKAT software package by Lee
et al. [28] with default parameters and age, sex, smoking status and education as covariates.
Both the burden test SKAT and the combined, “optimal” test SKAT-O resulted in non-signifi-
cant p-values (p = 0.39 and p = 0.33, respectively). We conclude that in our sample, the N100
amplitude at electrode position Cz cannot be explained by association with rare variants.
Results
EEG Analyses
Among the six SNPs studied, stepwise linear regression including the covariates age, sex, smok-
ing status and education revealed a significant effect of rs1044396 (genotype distribution: TT fre-
quency 0.287, CT frequency: 0.497, CC frequency: 0.216) on N100-amplitude (F = 16.06,
P< 0.0001). Mean amplitude values for the three rs1044396 genotype groups were:
TT = 0.777 μV (SD 0.805), CT = 1.026 μV (SD 1.075) and CC = 1.093 μV (SD 0.821). See Table 3
Table 3. Genotype Effects on N100 Event-Related Potential (Cz).
Parameter DF F-Value Original P-Value Beta
Unconstrained Genetic Model
Sex 1 10.39 0.0013 Females 0.22







Genotype 2 16.06 <0.0001 -0.23 (TT)
-0.07 (TC)
0.00 (CC)





Sex 1 6.12 0.0134 Females 0.21







Genotype 1 30.46 <0.0001 -0.18
Sex*Genotype 1 3.11 0.0782 Females-0.17
Linear Regression models after stepwise backward selection of variables (n = 1,705 subjects). Top: Unconstrained genetic model (DF = 11; p < .0001; R²
= 0.11; β = 0.95). Bottom: Recessive genetic model (DF = 9; p < .0001; R² = 0.11; β = 0.90). AC = Aachen, BE = Berlin, BN = Bonn, DU = Düsseldorf,
ER = Erlangen, MA = Mannheim, MZ = Mainz.
doi:10.1371/journal.pone.0152984.t003
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for further details. A comparable association was obtained for rs1044397 but not for the remain-
ing four SNPs. Homozygous rs1044396 C-allele carriers show the highest and homozygous T-
allele carriers the lowest N100-amplitude (Figs 2 and 3a, Table 3), the effect is most pronounced
in the left prefrontal and temporo-parietal cortex as revealed by current density source analyses
of N100 (Tables 4 and 5, Fig 3b). Applying a recessive genotype model (TT vs. TC + CC), a sig-
nificant genotype effect was observed (F = 30.46, P< 0.0001) (Table 3). Stronger genotype effects
on N100 were seen in females (F = 13.60, P< 0.0001,; recessive model: F = 26.38, P< 0.0001)
than in males (F = 3.77, P< 0.0235; recessive model: F = 6.87, P = 0.0089) (Fig 3a).
Linear regression analyses using data on genetic variants obtained by complete exon 5
sequencing confirmed the association results for rs1044397 and rs1044396 (both: P< 10−9)
with no additional common or rare single marker being significantly associated with N100
(genotype and sequencing data available upon request).
Behavioral Results
Mean reaction time for the three rs1044396 genotype groups were: TT = 363.62 ms (SD 81.76),
CT = 357.98 ms (SD 76.44) and CC = 364.37 ms (SD 79.41). In statistical analyses analogous to
the EEG data set no main effect of genotype on reaction time was found (unconstrained model:
F = 1.25, P = 0.2872; recessive model: F = 0.88, P = 0.41). However, a genotypesex interaction
effect was seen on reaction time (unspecified genetic model: F = 4.45, P = 0.0118; recessive
genetic model: F = 8.05, P = 0.0046): In females the TT genotype was associated with higher
reaction times while in males it was associated with lower reaction times. See Table 6 for fur-
ther details. Significant genotype effects on reaction time were observed in females:
TT = 370.41 ms (SD 84.98); CT = 354.38 ms (SD 75.52), CC = 364.75 ms (SD 82.25) (F = 5.31,
P = 0.0051; recessive genetic model: F = 7.48, P = 0.0063). See also Table 7. Largely identical
results were obtained for the neighboring SNP rs1044397.
Discussion
We found an association of rs1044396 with N100 amplitude elicited by a standard auditory
oddball paradigm with the C allele being associated with higher N100 amplitude, an effect that
was pronounced in females. Furthermore there was a genotypesex effect on reaction time in
this task. Similar results were obtained for rs1044397 but not for the other 4 CHRNA4 exon 5
SNPs studied.
Fig 2. Event-related potentials (ERPs) incl. N100 during auditory oddball task (target responses) at
electrode positions Fz and Cz for rs1044396 genotype groups. Note: response curves are uncorrected for
covariates.
doi:10.1371/journal.pone.0152984.g002
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Our results are consistent with previous literature in that we found an effect of common
CHRNA4 variants on cognition (see Greenwood et al. for a recent review) [7]. The results add
to the existing literature in several ways. To our knowledge this is only the second study look-
ing at CHRNA4 exon 5 genotype effects on stimulus processing and attention outside the visual
system [7]. Only Espeseth et al. [12] studied the effect of rs1044396 on processing of auditory
stimuli with EEG event-related potentials in a small sample of 42 subjects distributed over the
three genotypes (CC, CT, TT). Contrary to our results they found that TT homozygotes exhib-
ited higher N100 amplitudes than carriers of the C allele. Sample bias, population heterogeneity
and/or other differences in the composition of the two study samples may account for the
Fig 3. Quartile-quartile boxplot with genotype rs1044396 effects on event-related potential N100
amplitude (standardized values at electrode position Cz) in the general population. a) Top: Genotype
effects in the entire sample (males and females). Bottom: Genotype effects separately depicted for males
and females. Stepwise linear regression analysis of the event-related potential N100 at vertex electrode
position Cz, with age, gender, education, smoking status and study site as covariates and testing for up to
3-factor interactions among the predictors, revealed a significant genotype effect (for details see results
section). b) Functional neuroimaging sLORETA current density analyses of genotype groups with covariates
age, gender, study site. Top: Current density for genotype groups (P < 0.01). Bottom: genotype group
contrasts (t-values corrected for multiple testing). Independent of genotype, the strongest N100 activation
maximum is seen in the left temporal lobe followed by a maximum in the frontal lobe mostly in the left
hemisphere. This is consistent with intracortical recordings [44–46] as well as earlier LORETA studies
conducted by us [21, 23] using comparable task conditions. For details on genotype effects see result
section.
doi:10.1371/journal.pone.0152984.g003
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Table 4. sLORETA: N100 Brain Activation Maxima.
Region x y Z BA T
TT
Temporal Lobe -15 -10 -12 28 2.97
Temporal Lobe -15 -11 -16 34 2.95
Temporal Lobe -20 -20 -12 35 2.87
Frontal Lobe -5 4 -13 25 2.78
Temporal Lobe -20 -29 -3 27 2.75
Cingulate Cortex -15 -34 -7 30 2.73
Temporal Lobe -20 -6 -29 36 2.70
Frontal Lobe -5 13 -22 11 2.53
Temporal Lobe -20 3 -34 38 2.50
Sub-lobar Insula -40 -9 5 13 2.48
Parietal Lobe -15 -44 -6 19 2.46
Temporal Lobe -25 -2 -34 20 2.46
Temporal Lobe -25 -40 -15 37 2.40
TC
Temporal Lobe -64 -9 5 22 3.01
Temporal Lobe -64 -9 10 42 2.99
Frontal Lobe -54 -9 10 43 2.93
Occipital Lobe 5 -93 -8 18 2.86
Temporal Lobe -59 -5 -4 21 2.86
Anterior Cingulate 15 -7 46 24 2.82
Occipital Lobe 5 -92 -4 17 2.81
Temporal Lobe -10 -34 2 27 2.75
Cingulate Cortex -15 -34 -7 30 2.71
Frontal Lobe 59 6 27 9 2.70
Sub-lobar Insula -45 -9 5 13 2.68
Temporal Lobe -20 -25 -7 28 2.68
Temporal Lobe -20 -20 -12 35 2.66
Frontal Lobe -59 5 9 44 2.63
Temporal Lobe -15 -11 -16 34 2.61
Parietal Lobe 50 -27 47 40 2.58
Parietal Lobe -15 -44 -6 19 2.56
Temporal Lobe -20 -39 -6 36 2.49
Temporal Lobe -54 -19 6 41 2.49
Frontal Lobe 0 0 -4 25 2.45
Posterior Cingulate 5 -13 28 23 2.43
Frontal Lobe 10 -12 47 31 2.41
CC
Temporal Lobe -15 -10 -12 28 2.90
Temporal Lobe -15 -11 -16 34 2.86
Temporal Lobe -20 -20 -12 35 2.81
Temporal Lobe -20 -29 -3 27 2.75
Frontal Lobe 0 0 -4 25 2.74
Cingulate Cortex -15 -34 -7 30 2.72
Temporal Lobe -20 -6 -29 36 2.58
Sub-lobar Insula -40 -9 5 13 2.52
Parietal Lobe -15 -44 -6 19 2.47
(Continued)
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different genotype effects found. In the Espeseth study the sample consisted of somewhat older
subjects (mean age across genotype groups: 59.5–63.9 years) with above-average intelligence
(mean IQ across genotype groups: 121 to 125). In our study (total sample) mean age across
genotype groups ranged from 34.6 to 37.0 years, and mean IQ (assessed as verbal IQ by means
of the MWT-B) [29] with 104 to 107 may also be considered more “normal”. These age and IQ
related differences between the samples of the study published by Espeseth et al. [12] and our
study may account for the differences in rs1044396 genotype effects on N100 amplitude. Sec-
ond, the task design (two-stimulus standard oddball task in our study vs. oddball with addi-
tional distractor stimuli in the Espeseth study) was also non-identical. Though unlikely it
cannot be ruled out, that task-related differences may also contribute to the divergent results.
Third, though somewhat speculative, differences in the “genetic background” between the two
study populations may also play a role. Gene-gene interactions between CHRNA4 and the
dopamine system have been reported with regard to attention and response to nicotinic stimu-
lation [30, 31]. As the dopaminergic input to (prefrontal) cortical areas is fine tuned by the cho-
linergic system (see Mobascher and Winterer, for a review) [1] the “dopamine system context”
may affect the directionality of CHRNA4 genotype effects on cognition and neurophysiological
measures.
The behavioral results (reaction time) however, are—at least in females—consistent with
the effects of rs1044396 on processing speed in an earlier study reported by Reinvang et al.
[27], in which TT homozygotes performed more slowly than C allele carriers. On the other
hand, Schneider et al. [32] recently reported reduced processing speed associated with the
rs1044396 T-allele across three different visual tasks (Stroop, negative priming and Posner
task). Sex/gender effects were not reported in that study, though this mostly female (86%) sam-
ple was not suited to study sex by genotype interactions. However sex-specific effects of poly-
morphisms in the nicotinic system on cognition and behavior have been reported previously
[33, 34]. A possible explanation for the diverging results between the study reported by Schnei-
der et al., [32] and our study is the different sensory system that was stimulated (auditory vs.
visual). Another explanation might be differences in study population (e.g. age). In any case
the sample size and the population-based recruiting procedure are important strengths of the
current study with regard the “generalizability” of our results [13]. However, this data set is
consistent with the notion that common CHRNA4 exon 5 SNPs have effects on stimulus pro-
cessing and cognition beyond the visual system which has been more extensively studied in
that regard [7]. Furthermore our electrophysiological “brain imaging” approach using LOR-
ETA to map genotype differences on the N100 ERP provides new insights into the effect of
CHRNA4 on regional “brain activation”. Greenwood et al. [7] suggest the temporo-parietal
junction to be a critical region for CHRNA4 genotype effects. Our data are by and large consis-
tent with this notion but also point to more widespread effects including other cortical regions
including prefrontal areas.
Table 4. (Continued)
Region x y Z BA T
Temporal Lobe -50 -9 5 22 2.43
N100 current density peak maxima as identified by sLORETA in genotype rs1044396 groups (TT, TC, TT)
corrected for multiple testing with covariates age, gender and study site during auditory oddball task (target
condition) with corresponding Montreal Neurological Institute (MNI) x y z coordinates of peak EEG-
response (t-value) in sLORETA anatomical standard space. BA = Brodman Area.
doi:10.1371/journal.pone.0152984.t004
CHRNA4 Polymorphisms Affect EEG N100 Amplitude
PLOS ONE | DOI:10.1371/journal.pone.0152984 April 7, 2016 11 / 17
Table 5. N100 sLORETAGenotype Group Comparisons.
Region BA X Y Z T
TT vs TC
Frontal Lobe 9 35 41 35 3.52
Frontal Lobe 8 35 36 40 3.38
Frontal Lobe 46 45 40 26 3.30
Frontal Lobe 10 35 45 25 3.21
Frontal Lobe 6 5 45 35 2.80
Anterior Cingulate 32 15 35 21 2.80
Frontal Lobe 45 54 29 3 2.74
Frontal Lobe 11 5 53 -11 2.65
Frontal Lobe 13 45 25 8 2.63
Frontal Lobe 47 54 29 -1 2.62
TT vs CC
Frontal Lobe 9 -54 6 32 3.66
Frontal Lobe 6 -59 6 27 3.61
Frontal Lobe 44 -50 11 22 3.53
Frontal Lobe 45 -54 11 22 3.50
Frontal Lobe 10 -10 39 -6 3.38
Frontal Lobe 11 -5 48 -11 3.36
Frontal Lobe 4 -59 -4 23 3.36
Anterior Cingulate 24 -5 29 -1 3.35
Frontal Lobe 8 -50 7 41 3.28
Frontal Lobe 46 -45 21 22 3.24
Frontal Lobe 47 -20 29 -6 3.20
Frontal Lobe 32 -20 39 12 3.17
Frontal Lobe 25 5 28 -18 3.17
Frontal Lobe 43 -50 -4 14 3.11
Temporal Lobe 22 -64 -4 9 3.10
Frontal Lobe 13 -40 25 8 3.05
Anterior Cingulate 33 -5 20 17 3.04
Temporal Lobe 42 -59 -9 14 3.01
Parietal Lobe 2 -54 -18 29 2.88
Parietal Lobe 1 -64 -18 33 2.78
Parietal Lobe 40 -54 -23 29 2.68
Temporal Lobe 21 -59 0 -4 2.65
Temporal Lobe 41 -54 -19 10 2.63
Cingulate Gyrus 23 -5 -13 28 2.62
Temporal Lobe 38 -50 14 -9 2.60
TC vs CC
Frontal Lobe 9 50 26 36 3.92
Frontal Lobe 8 50 17 41 3.74
Frontal Lobe 6 54 7 41 3.74
Frontal Lobe 45 59 11 22 3.44
Frontal Lobe 46 54 25 22 3.43
Frontal Lobe 44 59 15 18 3.24
Frontal Lobe 4 64 -8 28 2.96
Parietal Lobe 3 64 -9 23 2.82
Parietal Lobe 43 64 -9 19 2.62
(Continued)
CHRNA4 Polymorphisms Affect EEG N100 Amplitude
PLOS ONE | DOI:10.1371/journal.pone.0152984 April 7, 2016 12 / 17
Table 5. (Continued)
Region BA X Y Z T
Frontal Lobe 10 40 45 25 2.41
N100 current density peak maxima as identified by sLORETA in genotype rs1044396 group contrast
analyses (TT vs TC, TT vs CC, TC vs CC) corrected for multiple testing with covariates age, gender and
study site during auditory oddball task (target condition) with corresponding Montreal Neurological Institute
(MNI) x y z coordinates of peak EEG-response (t-value) in sLORETA anatomical standard space.
BA = Brodman Area.
doi:10.1371/journal.pone.0152984.t005
Table 6. Genotype Effects on Reaction Time.
Parameter DF F-Value Original P-Value Beta
Unconstrained Genetic Model
Sex 1 0.13 0.7165 Females -1.09







Genotype 2 1.25 0.2872 -9.44 (TT)
-1.88 (TC)
0.00 (CC)





Sex 1 0.98 0.3222 Females -7.48







Genotype 1 0.68 0.4100 -8.15
Sex*Genotype 1 8.05 0.0046 Females 22.95
Linear Regression models fitted for N100 (Cz) performing stepwise backward selection of variables. Top: Unconstrained genetic model (DF = 11; p <
.0001; R² = 0.04; β = 362.5; n = 1,818). Bottom: Recessive genetic model (DF = 9; p < .0001; R² = 0.04; β = 361.3; n = 1,818). AC = Aachen, BE = Berlin,
BN = Bonn, DU = Düsseldorf, ER = Erlangen, MA = Mannheim, MZ = Mainz. The larger sample size (compared to the sample size with the N100
regression analyses) is due to subjects with available reaction time data but without artifact-free EEG from the original sample.
doi:10.1371/journal.pone.0152984.t006
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To our knowledge this is the first study investigating any naturally occurring genetic varia-
tion regarding its effect on the auditory N100 ERP in a population-based sample of this size.
The auditory N1 is considered as an endophenotype for schizophrenia [35, 36], and has been
shown to be substantially heritable (h = 0.4) [37]. Our finding of a CHRNA4 rs1044396 T-allele
associated N100 amplitude reduction in healthy subjects has two implications for future
research. First, it provides further evidence that N100 amplitude reduction might be a useful
phenotype in translational research and “outcome marker” for the development of drugs tar-
geting the nicotinic system. Second, it suggests that genetic variation in exon 5 of CHRNA4
might be associated with schizophrenia per se or perhaps schizophrenia-related outcome mea-
sures like treatment response. This hypothesis is by and large supported by the existing litera-
ture on rs1044396 effects on cognitive processes in which genotype differences in behavioral
and brain activity measures were similar to the differences that can be found between patients
and healthy controls [8, 9, 12, 38–42].
The results presented here do not provide further direct mechanistic inside in how the
investigated CHRNA4 SNPs (all noncoding) might exert their effect on cognition. This may be
considered a limitation of this work. However, it is largely ruled-out by the sequencing data
that unknown polymorphisms in the region are responsible for this effect and a recent paper
from our consortium provides first insights in how these silent SNPs may affect neurobiology
on the molecular and electrophysiological (cellular) level [25]. Our work lays the ground for
Table 7. Genotype Effects on Reaction Time in Females.
Parameter DF F-Value Original P-Value Beta
Unconstrained Genetic Model


















Genotype 1 7.48 0.0063 14.97
Linear Regression models fitted for N100 (Cz) performing stepwise backward selection of variables. Top:
Unconstrained genetic model (DF = 8; p < .0001; R² = 0.05; β = 360.5; n = 1,036). Bottom: Recessive
genetic model (DF = 7; p < .0001; R² = 0.05; β = 352.9; n = 1,036). AC = Aachen, BE = Berlin, BN = Bonn,
DU = Düsseldorf, ER = Erlangen, MA = Mannheim, MZ = Mainz. rs1044396 genotype = TT (frequency:
0.272), TC (frequency: 0.512), CC (frequency: 0.216).
doi:10.1371/journal.pone.0152984.t007
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future studies on how synonymous CHRNA4 exon 5 SNPs affect cognitive processes and how
they might be associated with neuropsychiatric disorders such as schizophrenia.
Supporting Information
S1 File. N100 Data. Provided are N100 amplitude values and information reg. study site, age,
sex and rs1044396 genotype for each study participant.
(TXT)
S2 File. Reaction Time Data. Provided are reaction times and information reg. study site, age,
sex and rs1044396 genotype for each study participant.
(TXT)
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